NunaBio Limited specializes in the production of synthetic DNA, offering custom DNA sequences that are unique in the market. Their innovative approach utilizes an entirely in-house, enzymatic, and cell-free process, allowing for the rapid synthesis of complex DNA sequences of multi-kilobase lengths. This technology is designed to meet the increasing global demand for high-quality synthetic DNA, which is essential for various applications, including mRNA templates, monoclonal antibodies, personalized medicine, and gene therapies. The company emphasizes scalability and speed, with the capability to deliver products within days while maintaining high purity and low costs.

In addition to custom DNA synthesis, NunaBio provides a range of services, including contract research and material supply, tailored to meet the specific needs of their clients. Their offerings encompass short oligonucleotides, linear and double-stranded DNA, gene fragments, and repetitive sequences, all of which can be customized according to client specifications. The versatility of their technology allows for the integration of various modifications and the production of homologous DNA fragments, making NunaBio a valuable partner in the biotechnology sector.

United Kingdom

NunaBio is a privately-owned specialist DNA synthesis and development company. We are engaged in CRO (Contract Research Organizations) and CDMO (Contract Development and Manufacturing Organisation) activities. The company has built a solid reputation for its R&D flexibility and innovative approach to complex and challenging projects.

NunaBio's core expertise is research and development into cell-free DNA synthesis, process optimisation, route design, scale-up and small-scale manufacture for clinical studies.

NunaBio Limited

Company Details